'Super-antibodies' could curb COVID-19 and help avert future pandemics
Elie Dolgin • June 22, 2021
Companies are designing next-generation antibodies modeled on those taken from unique individuals whose immune systems can neutralize any COVID-19 variant — and related coronaviruses, too.
The US Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) in late May to sotrovimab, providing a new therapeutic weapon in the fight against SARS-CoV-2—and future coronaviruses with pandemic potential.
According to analysts and researchers alike, so-called super-antibodies such as sotrovimab should have an edge over first-generation monoclonal antibody (mAb) therapies for COVID-19 because of their broad neutralization capacity in the face of emerging virus variants.
Continue reading at Nature Biotechnology.
As humans return to the Moon, researchers are trying to understand—and thwart—the biological toll of deep-space radiation.
Animals that researchers call “supersucklers” come back for their mother’s milk even after they can hunt, mate and fend for themselves.